Careteq Limited belongs to the Healthcare & Pharma sector. Filings by its managers are published through ASX. The last twelve months, up to 18 October 2026, brought 8 filings signed by 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 1,605 companies) published 4 filings over the same period, against 8 filings here.
There has been no open-market purchase by an insider of Careteq Limited for at least a year.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2024 · cache
8 of 8 declarations
Careteq Limited is a company in the health and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
Purchases our model currently ranks for the recommendations list.
All recommendations